Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Board changes

30 May 2024 07:00

RNS Number : 3612Q
Insig AI Plc
30 May 2024
 

30 May 2024

 

Insig AI

("Insig AI" or the "Company")

 

Board changes

 

Insig AI plc (AIM:INSG), the data science and machine learning solutions company announces the following changes to its board of directors (the "Board").

 

With immediate effect Colm McVeigh will be stepping down from the Board and his role as CEO to pursue other opportunities. Richard Bernstein has been appointed as Chief Executive Officer with immediate effect to devote more time to engaging with asset managers, prospective customers and commercialising Insig's product offering.

 

The Company also announces that Warren Pearson, Chief Technical Officer is stepping down from the Board, but staying within the business as a full-time employee. This change will allow Warren to focus time on product development and deployment of Insig's machine learning solutions.

 

Finally, Insig AI is pleased to announce the appointment of John Wilson as Independent Non-Executive Chairman with immediate effect.

 

John is a globally experienced Chairman and Chief Executive, with a strong background in the technology sector. He is currently the CEO of Bulgin Limited, a world leading manufacturer of sealed connectors and components and Independent Non-Executive Director of AIM quoted Volex plc. Previously, John previously held the roles of Senior Independent Director, Chair of the Audit Committee and Chair of the Remuneration Committee of Checkit plc (previously Elektron Technology plc), prior to which he was CEO of Elektron Technology Plc for almost a decade. John holds a degree in Engineering from the University of Durham.

 

Following the above changes the composition of the Board is as follows:

 

- Independent Non-Executive Chairman, John Wilson

- Independent Non-Executive Director, Richard Cooper

- Chief Executive Officer, Richard Bernstein

- Chief Product Officer, Steve Cracknell

 

Richard Bernstein, CEO commented: "I'm pleased to be appointed Chief Executive at a time when the priority for the business is to convert its strong machine learning repository and data science capabilities into client wins and revenues. Although sales cycles to large corporates for emerging technologies can take up to 18 months, with impending regulatory changes, our addressable market has enormous potential. Over time, my job will be to ensure that we fully capitalise on these substantial opportunities."

 

John Wilson commented: "I am delighted to be joining Insig AI at this exciting time. Having previously been involved in the business, as Strategic Adviser, I have had the opportunity to appreciate the significant potential for this business. I look forward to supporting Richard and the team in realising the true potential of Insig AI. "

 

The following additional information is provided in accordance with paragraph (g) of Schedule Two of the AIM Rules for Companies.

 

John Frederick Wilson (aged 48) holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

 

Previous Directorships or Partnerships

 

Volex Plc

Hartest Precision Instruments India Private Limited

JFW Agritech Ltd

Hartest Precision Instruments Limited

Regatta Midco Limited

Elektron Vision Inc.

Regatta Bidco Limied

Checkit UK Limited

Regatta Topco Limited

Elektron Eye Technology Limited

Regatta Holdco Limited

Elektron IP Limited

Bulgin Limited

Checkit Europe Limited

Bulgin Inc.

Elecktron Precision Instruments Limited

Munro Instruments Limited

Abbey Place (Fordham) Management Company Limited

Checkit Plc

Bulgin Connectors Limited

Elektron Enterprises 1 Limited

 

Mr Wilson and persons closely associated currently hold 800,000 ordinary shares in the Company.

 

There is no further information to be disclosed pursuant to Schedule Two Part (g) of the AIM Rules for Companies.

 

 

For further information, please visit www.insg.ai or contact:

Insig AI plc

Richard Bernstein, CEO

 

richard.bernstein@insg.ai

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold

+44 (0) 203 829 5000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKLLLZELEBBQ
Date   Source Headline
6th Sep 20247:00 amRNSDirector/PDMR Dealing
1st Aug 20247:00 amRNSDirector/PDMR Dealing
3rd Jul 20247:00 amRNSConvertible Loan Notes
21st Jun 20242:30 pmRNSHolding(s) in Company
10th Jun 202411:36 amRNSHolding(s) in Company
6th Jun 20247:00 amRNSGrant of options
5th Jun 20247:00 amRNSEquity Subscription and TVR
30th May 20246:28 pmRNSDirector/PDMR Dealing
30th May 20247:02 amRNSShare subscription, director dealing and TVR
30th May 20247:01 amRNSStrategic investment, revenue share and TVR
30th May 20247:00 amRNSBoard changes
2nd May 20247:00 amRNSShare subscription, director dealing and TVR
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.